HOME >> BIOLOGY >> NEWS
A 2002 disease threat offers lessons for avian flu preparedness

As public health experts discuss how best to prevent an avian flu epidemic in the United States, La Follette School of Public Affairs assistant professor Donald P. Moynihan has a few suggestions.

He outlines his ideas in a 2005 report, "Leveraging Collaborative Networks in Infrequent Emergency Situations," for the IBM Center for The Business of Government at the University of Wisconsin-Madison.

Moynihan's suggestions are rooted in the response to an outbreak of a disease in California and other western states that threatened the U.S. poultry industry in 2002 and 2003. A task force of state and federal responders was created to eliminate the threat of Exotic Newcastle Disease.

Moynihan, who joined UW-Madison this fall, has research and teaching interests in performance management, homeland security, citizen participation and public budgeting. In particular, he studies the selection and implementation of public management reforms. He is working on a book entitled "Rethinking Performance Management," to be published by Georgetown University Press.

Like bird flu, Newcastle Disease is lethal to poultry and transfers via bird feces, says Moynihan. The primary challenge facing the task force was to identify the spread of the disease, quarantine affected areas, test or euthanize millions of birds, and clean affected premises and dispose of carcasses in biosecure ways. As states and the federal government plan to deal with the threat of bird flu, eliminating the spread of the disease among birds will be a critical part of any response, Moynihan says.

No single organization is capable of dealing with an unusual, infrequent and large-scale threat such as bird flu, Moynihan says, meaning that collaborative networks like the Newcastle Disease task force will necessarily be part of the solution.

From a public management perspective, networks are a set of connected actors involved in the delivery of services. These multiple organi
'"/>

Contact: Donald P. Moynihan
dmoynihan@lafollette.wisc.edu
608-263-6633
University of Wisconsin-Madison
6-Dec-2005


Page: 1 2

Related biology news :

1. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
2. Antioxidant overload may underlie a heritable human disease
3. Female gender provides an advantage in renal diseases
4. The female advantage in kidney disease does not extend to diabetic women
5. Link between sunspots, rain helps predict disease in east Africa
6. Cornell scientists link E. coli bacteria to Crohns disease
7. Taking a supplement of glycine helps prevent degenerative diseases such as arthrosis or osteoporosis
8. Link identified between Alzheimers disease and glaucoma
9. Huntingtons disease study shows animal models on target
10. Geisinger scientist seeks cure for Lou Gehrigs disease, creating device to find treatment
11. News conference on plant diseases and issues important to California

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: disease threat offers lessons for avian flu preparedness

(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: